NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells

Noritaka Yamaguchi, Tetsunari Oyama, Emi Ito, Hitoshi Satoh, Sakura Azuma, Mitsuhiro Hayashi, Ken Shimizu, Reiko Honma, Yuka Yanagisawa, Akira Nishikawa, Mika Kawamura, Jun Ichi Imai, Susumu Ohwada, Kuniaki Tatsuta, Jun Ichiro Inoue, Kentaro Senba, Shinya Watanabe

    Research output: Contribution to journalArticle

    129 Citations (Scopus)

    Abstract

    ErbB2-negative breast tumors represent a significant therapeutic hurdle because of a lack of effective molecular targets. Although NOTCH proteins are known to be involved in mammary tumorigenesis, the functional significance of these proteins in ErbB2-negative breast tumors is not clear. In the present study, we examined the expression of activated NOTCH receptors in human breast cancer cell lines, including ErbB2-negative and ErbB2-positive cell lines. Activated NOTCH1 and NOTCH3 proteins generated by γ-secretase were detected in most of the cell lines tested, and both proteins activated CSL-mediated transcription. Down-regulation of NOTCH1 by RNA interference had little or no suppressive effect on the proliferation of either ErbB2-positive or ErbB2-negative cell lines. In contrast, down-regulation of NOTCH3 significantly suppressed proliferation and promoted apoptosis of the ErbB2-negative tumor cell lines. Down-regulation of NOTCH3 did not have a significant effect on the ErbB2-positive tumor cell lines. Down-regulation of CSL also suppressed the proliferation of ErbB2-negative breast tumor cell lines, indicating that the NOTCH-CSL signaling axis is involved in cell proliferation. Finally, NOTCH3 gene amplification was detected in a breast tumor cell line and one breast cancer tissue specimen even though the frequency of NOTCH3 gene amplification was low (<1%). Taken together, these findings indicate that NOTCH3-mediated signaling rather than NOTCH1-mediated signaling plays an important role in the proliferation of ErbB2-negative breast tumor cells and that targeted suppression of this signaling pathway may be a promising strategy for the treatment of ErbB2-negative breast cancers.

    Original languageEnglish
    Pages (from-to)1881-1888
    Number of pages8
    JournalCancer Research
    Volume68
    Issue number6
    DOIs
    Publication statusPublished - 2008 Mar 15

    Fingerprint

    Breast Neoplasms
    Tumor Cell Line
    Down-Regulation
    Cell Line
    Gene Amplification
    Proteins
    Amyloid Precursor Protein Secretases
    RNA Interference
    Carcinogenesis
    Breast
    Cell Proliferation
    Apoptosis

    ASJC Scopus subject areas

    • Cancer Research
    • Oncology

    Cite this

    Yamaguchi, N., Oyama, T., Ito, E., Satoh, H., Azuma, S., Hayashi, M., ... Watanabe, S. (2008). NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Research, 68(6), 1881-1888. https://doi.org/10.1158/0008-5472.CAN-07-1597

    NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. / Yamaguchi, Noritaka; Oyama, Tetsunari; Ito, Emi; Satoh, Hitoshi; Azuma, Sakura; Hayashi, Mitsuhiro; Shimizu, Ken; Honma, Reiko; Yanagisawa, Yuka; Nishikawa, Akira; Kawamura, Mika; Imai, Jun Ichi; Ohwada, Susumu; Tatsuta, Kuniaki; Inoue, Jun Ichiro; Senba, Kentaro; Watanabe, Shinya.

    In: Cancer Research, Vol. 68, No. 6, 15.03.2008, p. 1881-1888.

    Research output: Contribution to journalArticle

    Yamaguchi, N, Oyama, T, Ito, E, Satoh, H, Azuma, S, Hayashi, M, Shimizu, K, Honma, R, Yanagisawa, Y, Nishikawa, A, Kawamura, M, Imai, JI, Ohwada, S, Tatsuta, K, Inoue, JI, Senba, K & Watanabe, S 2008, 'NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells', Cancer Research, vol. 68, no. 6, pp. 1881-1888. https://doi.org/10.1158/0008-5472.CAN-07-1597
    Yamaguchi, Noritaka ; Oyama, Tetsunari ; Ito, Emi ; Satoh, Hitoshi ; Azuma, Sakura ; Hayashi, Mitsuhiro ; Shimizu, Ken ; Honma, Reiko ; Yanagisawa, Yuka ; Nishikawa, Akira ; Kawamura, Mika ; Imai, Jun Ichi ; Ohwada, Susumu ; Tatsuta, Kuniaki ; Inoue, Jun Ichiro ; Senba, Kentaro ; Watanabe, Shinya. / NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. In: Cancer Research. 2008 ; Vol. 68, No. 6. pp. 1881-1888.
    @article{450fc59e394641e085b19bc727f0a245,
    title = "NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells",
    abstract = "ErbB2-negative breast tumors represent a significant therapeutic hurdle because of a lack of effective molecular targets. Although NOTCH proteins are known to be involved in mammary tumorigenesis, the functional significance of these proteins in ErbB2-negative breast tumors is not clear. In the present study, we examined the expression of activated NOTCH receptors in human breast cancer cell lines, including ErbB2-negative and ErbB2-positive cell lines. Activated NOTCH1 and NOTCH3 proteins generated by γ-secretase were detected in most of the cell lines tested, and both proteins activated CSL-mediated transcription. Down-regulation of NOTCH1 by RNA interference had little or no suppressive effect on the proliferation of either ErbB2-positive or ErbB2-negative cell lines. In contrast, down-regulation of NOTCH3 significantly suppressed proliferation and promoted apoptosis of the ErbB2-negative tumor cell lines. Down-regulation of NOTCH3 did not have a significant effect on the ErbB2-positive tumor cell lines. Down-regulation of CSL also suppressed the proliferation of ErbB2-negative breast tumor cell lines, indicating that the NOTCH-CSL signaling axis is involved in cell proliferation. Finally, NOTCH3 gene amplification was detected in a breast tumor cell line and one breast cancer tissue specimen even though the frequency of NOTCH3 gene amplification was low (<1{\%}). Taken together, these findings indicate that NOTCH3-mediated signaling rather than NOTCH1-mediated signaling plays an important role in the proliferation of ErbB2-negative breast tumor cells and that targeted suppression of this signaling pathway may be a promising strategy for the treatment of ErbB2-negative breast cancers.",
    author = "Noritaka Yamaguchi and Tetsunari Oyama and Emi Ito and Hitoshi Satoh and Sakura Azuma and Mitsuhiro Hayashi and Ken Shimizu and Reiko Honma and Yuka Yanagisawa and Akira Nishikawa and Mika Kawamura and Imai, {Jun Ichi} and Susumu Ohwada and Kuniaki Tatsuta and Inoue, {Jun Ichiro} and Kentaro Senba and Shinya Watanabe",
    year = "2008",
    month = "3",
    day = "15",
    doi = "10.1158/0008-5472.CAN-07-1597",
    language = "English",
    volume = "68",
    pages = "1881--1888",
    journal = "Journal of Cancer Research",
    issn = "0008-5472",
    publisher = "American Association for Cancer Research Inc.",
    number = "6",

    }

    TY - JOUR

    T1 - NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells

    AU - Yamaguchi, Noritaka

    AU - Oyama, Tetsunari

    AU - Ito, Emi

    AU - Satoh, Hitoshi

    AU - Azuma, Sakura

    AU - Hayashi, Mitsuhiro

    AU - Shimizu, Ken

    AU - Honma, Reiko

    AU - Yanagisawa, Yuka

    AU - Nishikawa, Akira

    AU - Kawamura, Mika

    AU - Imai, Jun Ichi

    AU - Ohwada, Susumu

    AU - Tatsuta, Kuniaki

    AU - Inoue, Jun Ichiro

    AU - Senba, Kentaro

    AU - Watanabe, Shinya

    PY - 2008/3/15

    Y1 - 2008/3/15

    N2 - ErbB2-negative breast tumors represent a significant therapeutic hurdle because of a lack of effective molecular targets. Although NOTCH proteins are known to be involved in mammary tumorigenesis, the functional significance of these proteins in ErbB2-negative breast tumors is not clear. In the present study, we examined the expression of activated NOTCH receptors in human breast cancer cell lines, including ErbB2-negative and ErbB2-positive cell lines. Activated NOTCH1 and NOTCH3 proteins generated by γ-secretase were detected in most of the cell lines tested, and both proteins activated CSL-mediated transcription. Down-regulation of NOTCH1 by RNA interference had little or no suppressive effect on the proliferation of either ErbB2-positive or ErbB2-negative cell lines. In contrast, down-regulation of NOTCH3 significantly suppressed proliferation and promoted apoptosis of the ErbB2-negative tumor cell lines. Down-regulation of NOTCH3 did not have a significant effect on the ErbB2-positive tumor cell lines. Down-regulation of CSL also suppressed the proliferation of ErbB2-negative breast tumor cell lines, indicating that the NOTCH-CSL signaling axis is involved in cell proliferation. Finally, NOTCH3 gene amplification was detected in a breast tumor cell line and one breast cancer tissue specimen even though the frequency of NOTCH3 gene amplification was low (<1%). Taken together, these findings indicate that NOTCH3-mediated signaling rather than NOTCH1-mediated signaling plays an important role in the proliferation of ErbB2-negative breast tumor cells and that targeted suppression of this signaling pathway may be a promising strategy for the treatment of ErbB2-negative breast cancers.

    AB - ErbB2-negative breast tumors represent a significant therapeutic hurdle because of a lack of effective molecular targets. Although NOTCH proteins are known to be involved in mammary tumorigenesis, the functional significance of these proteins in ErbB2-negative breast tumors is not clear. In the present study, we examined the expression of activated NOTCH receptors in human breast cancer cell lines, including ErbB2-negative and ErbB2-positive cell lines. Activated NOTCH1 and NOTCH3 proteins generated by γ-secretase were detected in most of the cell lines tested, and both proteins activated CSL-mediated transcription. Down-regulation of NOTCH1 by RNA interference had little or no suppressive effect on the proliferation of either ErbB2-positive or ErbB2-negative cell lines. In contrast, down-regulation of NOTCH3 significantly suppressed proliferation and promoted apoptosis of the ErbB2-negative tumor cell lines. Down-regulation of NOTCH3 did not have a significant effect on the ErbB2-positive tumor cell lines. Down-regulation of CSL also suppressed the proliferation of ErbB2-negative breast tumor cell lines, indicating that the NOTCH-CSL signaling axis is involved in cell proliferation. Finally, NOTCH3 gene amplification was detected in a breast tumor cell line and one breast cancer tissue specimen even though the frequency of NOTCH3 gene amplification was low (<1%). Taken together, these findings indicate that NOTCH3-mediated signaling rather than NOTCH1-mediated signaling plays an important role in the proliferation of ErbB2-negative breast tumor cells and that targeted suppression of this signaling pathway may be a promising strategy for the treatment of ErbB2-negative breast cancers.

    UR - http://www.scopus.com/inward/record.url?scp=40949092796&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=40949092796&partnerID=8YFLogxK

    U2 - 10.1158/0008-5472.CAN-07-1597

    DO - 10.1158/0008-5472.CAN-07-1597

    M3 - Article

    C2 - 18339869

    AN - SCOPUS:40949092796

    VL - 68

    SP - 1881

    EP - 1888

    JO - Journal of Cancer Research

    JF - Journal of Cancer Research

    SN - 0008-5472

    IS - 6

    ER -